PROCEPT INC
4, 1998-09-10
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: PROCEPT INC, SC 13D/A, 1998-09-10
Next: PROCEPT INC, 4, 1998-09-10



UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 4
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities  Exchange Act of 1934, Section
17(a) of the Public Utility  Holding Company Act of 1935 or Section 30(f) of the
Investment Company Act of 1940
( ) Check this box if no longer subject to Section 16.
Form 4 or Form 5 obligations may continue. See Instructions 1(b).
1. Name and Address of Reporting Person
   Rosenwald, Lindsay A.
   c/o Paramount Capital Asset Management, Inc.
   787 Seventh Avenue
   48th Floor
   New York, NY  10019
2. Issuer Name and Ticker or Trading Symbol
   PROCEPT
   PRCT
3. IRS or Social Security Number of Reporting Person (Voluntary)
   
4. Statement for Month/Year
   AUGUST/98
5. If Amendment, Date of Original (Month/Year)
   
6. Relationship of Reporting Person(s) to Issuer (Check all applicable)
   (X) Director (X) 10% Owner ( ) Officer (give title below) ( ) Other
   (specify below)
   
7. Individual or Joint/Group Filing (Check Applicable Line)
   (X) Form filed by One Reporting Person
   ( ) Form filed by More than One Reporting Person
<TABLE>
<CAPTION>
___________________________________________________________________________________________________________________________________
 Table I -- Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned                                                 |
___________________________________________________________________________________________________________________________________|
1. Title of Security       |2.    |3.    |4.Securities Acquired (A)         |5.Amount of        |6.Dir |7.Nature of Indirect       |
                           | Transaction |  or Disposed of (D)              |  Securities       |ect   |  Beneficial Ownership     |
                           |      |      |                                  |  Beneficially     |(D)or |                           |
                           |      |    | |                  | A/|           |  Owned at         |Indir |                           |
                           | Date |Code|V|    Amount        | D |    Price  |  End of Month     |ect(I)|                           |
___________________________________________________________________________________________________________________________________|
<S>                        <C>    <C>  <C><C>               <C> <C>         <C>                 <C>    <C>
___________________________________________________________________________________________________________________________________|

<PAGE>
<CAPTION>
___________________________________________________________________________________________________________________________________
 Table II -- Derivative Securitites Acquired, Disposed of, or Beneficially Owned                                                   |
___________________________________________________________________________________________________________________________________|
1.Title of Derivative |2.Con-  |3.   |4.    |5.Number of De |6.Date Exer|7.Title and Amount  |8.Price|9.Number    |10.|11.Nature of|
  Security            |version |Transaction | rivative Secu |cisable and|  of Underlying     |of Deri|of Deriva   |Dir|Indirect    |
                      |or Exer |     |      | rities Acqui  |Expiration |  Securities        |vative |tive        |ect|Beneficial  |
                      |cise    |     |      | red(A) or Dis |Date(Month/|                    |Secu   |Securities  |(D)|Ownership   |
                      |Price of|     |      | posed of(D)   |Day/Year)  |                    |rity   |Benefi      |or |            |
                      |Deriva- |     |      |               |Date |Expir|                    |       |ficially    |Ind|            |
                      |tive    |     |      |           | A/|Exer-|ation|   Title and Number |       |Owned at    |ire|            |
                      |Secu-   |     |    | |           | D |cisa-|Date |   of Shares        |       |End of      |ct |            |
                      |rity    |Date |Code|V|  Amount   |   |ble  |     |                    |       |Month       |(I)|            |
___________________________________________________________________________________________________________________________________|
<S>                   <C>      <C>   <C>  <C><C>        <C> <C>   <C>   <C>          <C>     <C>     <C>          <C> <C>
Placement Option (1)  |$110,000|8/10/|J(2)| |2.5 (1)    |A  |10/9/|4/9/ |Units(1)    |2.5    |(2)    |2.5(1)      |I  |(3)         |
                      |        |98(2)|    | |           |   |98   |03   |            |       |       |            |   |            |
- -----------------------------------------------------------------------------------------------------------------------------------|
Placement Option (1)  |$110,000|8/10/|J(2)| |2.967(1)   |A  |10/9/|4/9/ |Units(1)    |2.967  |(2)    |2.967(1)    |D  |            |
                      |        |98(2)|    | |           |   |98   |03   |            |       |       |            |   |            |
- -----------------------------------------------------------------------------------------------------------------------------------|
Advisory Option (1)   |$110,000|8/10/|J(4)| |10.975(1)  |A  |10/9/|4/9/ |Units(1)    |10.975 |(2)    |10.975(1)   |D  |            |
                      |        |98(4)|    | |           |   |98   |03   |            |       |       |            |   |            |
___________________________________________________________________________________________________________________________________|
</TABLE>
Explanation of Responses:
(1)  The Placement  Options and Advisory  Options are options to purchase  units
     each  consisting  of (i)  20,000  shares of Common  Stock and (ii)  Class C
     Warrants to purchase 20,000 shares of Common Stock.
(2)  Pursuant to a Placement Agency  Agreement  between the Issuer and Paramount
     Capital,   Inc.,  Paramount  Capital,   Inc.  designated   recipients  (the
     "Paramount  Option  Designees")  of the  Placement  Options.  The Reporting
     Person was among the Paramount Option Designees and received such Placement
     Options in connection with a private  placement of securities of the Issuer
     of which Paramount  Capital,  Inc. acted as placement  agent. The Placement
     Options  become  exerciseable  within 60 days of August 10,  1998.  
(3)  The Reporting  Person is the President  and sole  shareholder  of Paramount
     Capital  Asset  Management,  Inc.  ("Paramount").  Paramount is the General
     Partner of the Aries  Domestic  Fund,  L.P.  (the  "Partnership")  and also
     serves as the  Investment  Manager to The Aries Trust (the "Trust" and with
     the  Partnership,  the "Aries  Funds"),  a Cayman Islands trust.  The Aries
     Funds  each  owns  securities  of  the  Issuer.  Dr.  Rosenwald   disclaims
     beneficial  ownership of the securities held by the Aries Funds,  except to
     the extent of his pecuniary interest therein, if any. Furthermore, pursuant
     to  certain  agreements,  the Aries  Funds  have the right to  designate  a
     majority of the members of the Issuer's  Board of Directors, however,  Dr.
     Rosenwald disclaims any status as a Director of the Issuer himself.
(4)  Pursuant to a Financial Advisory Agreement between the Issuer and Paramount
     Capital,   Inc.,  Paramount  Capital,   Inc.  designated   recipients  (the
     "Paramount  Advisory  Option  Designees")  of  the  Advisory  Options.  The
     Reporting  Person was among the  Paramount  Advisory  Option  Designees and
     received such Advisory  Options in connection  with a private  placement of
     securities of the Issuer. The Advisory Options become  exerciseable  within
     60 days of August 10, 1998.



**SIGNATURE OF REPORTING PERSON
/s/Lindsay A. Rosenwald, M.D.
- ---------------------------------
Lindsay A. Rosenwald, M.D.

DATE
9/10/98

**   Intentional misstatements or omissions of facts constitute Federal Criminal
     Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note:   File three copies of this Form, one of which must be manually signed.
        If space provided is insufficient, see Instruction 6 for procedure.


Potential persons who are to respond to the collection of information  contained
in SEC 1474  (7-96)  this  form are not  required  to  respond  unless  the form
displays a currently valid OMB Number.

                                   Page 2 of 2






© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission